Recognizing the importance of identifying new biomedical interventions and integrating state-of-the-art methods and technologies to the research priority areas, this working group includes expertise in the areas of antiretrovirals (ARV) for prevention, Multipurpose Prevention Treatments (MPT) and broadly neutralizing antibodies (bnAbs). The Working Group brings expertise in developing and testing novel products and delivery systems.


HPTN Biomedical Sciences Working Group

image coming soon
Joe Eron


Elaine Abrams
Elaine Abrams



Biomedical Sciences Working Group Group Contact